[
  {
    "ts": "2025-10-17T04:25:32+00:00",
    "headline": "How Recent Developments Are Reshaping the Viatris Investment Story",
    "summary": "Viatris stock has seen its Fair Value Estimate rise slightly from $11.43 to $11.88 per share, reflecting cautious optimism among analysts. This modest increase follows incremental improvements in the company's revenue growth forecast and a positive response to new product rollouts. Stay tuned to discover how you can track ongoing updates to Viatris's evolving market narrative. What Wall Street Has Been Saying üêÇ Bullish Takeaways Needham upgraded Amphastar after the FDA approval of AMP-002...",
    "url": "https://finance.yahoo.com/news/recent-developments-reshaping-viatris-investment-042532810.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "526d08e3-7c11-3f2c-8d1a-7db8adf49c68",
      "content": {
        "id": "526d08e3-7c11-3f2c-8d1a-7db8adf49c68",
        "contentType": "STORY",
        "title": "How Recent Developments Are Reshaping the Viatris Investment Story",
        "description": "",
        "summary": "Viatris stock has seen its Fair Value Estimate rise slightly from $11.43 to $11.88 per share, reflecting cautious optimism among analysts. This modest increase follows incremental improvements in the company's revenue growth forecast and a positive response to new product rollouts. Stay tuned to discover how you can track ongoing updates to Viatris's evolving market narrative. What Wall Street Has Been Saying üêÇ Bullish Takeaways Needham upgraded Amphastar after the FDA approval of AMP-002...",
        "pubDate": "2025-10-17T04:25:32Z",
        "displayTime": "2025-10-17T04:25:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pVOKMAerbRsXv56pHka6Lw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EmyGBi4taxQExvvwka_9KQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-reshaping-viatris-investment-042532810.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-reshaping-viatris-investment-042532810.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]